Scarica l'app Stockscreener
6.41
8.43%
-0.59
Dopo l'orario di chiusura:
6.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.00
Aprire:
$6.49
Volume 24 ore:
4.62M
Relative Volume:
1.15
Capitalizzazione di mercato:
$1.17B
Reddito:
$847.25M
Utile/perdita netta:
$-284.86M
Rapporto P/E:
-2.7991
EPS:
-2.29
Flusso di cassa netto:
$-112.35M
1 W Prestazione:
-16.64%
1M Prestazione:
-23.05%
6M Prestazione:
-49.25%
1 anno Prestazione:
+34.10%
Intervallo 1D:
$6.28
$6.59
Intervallo di 1 settimana:
$6.28
$7.715
Portata 52W:
$3.81
$23.86
Novavax Inc Stock (NVAX) Company Profile
Nome
Novavax Inc
Settore
Industria
Telefono
240-268-2000
Indirizzo
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Confronta NVAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
6.41 | 1.17B | 847.25M | -284.86M | -112.35M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-28 | Iniziato | BTIG Research | Buy |
| 2024-07-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Reiterato | B. Riley Securities | Buy |
| 2022-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2022-12-02 | Iniziato | Jefferies | Hold |
| 2022-09-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2022-02-22 | Ripresa | Jefferies | Buy |
| 2022-01-21 | Iniziato | Cowen | Outperform |
| 2021-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Iniziato | Jefferies | Buy |
| 2020-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Reiterato | B. Riley FBR | Buy |
| 2020-06-29 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Reiterato | B. Riley FBR | Buy |
| 2020-05-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-08-14 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-12-11 | Iniziato | Oppenheimer | Outperform |
| 2018-11-26 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Aggiornamento | Seaport Global Securities | Neutral → Buy |
Mostra tutto
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out - WSJ
Top vaccine official’s ouster sends biotech stocks tumbling - The Boston Globe
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief - MarketScreener
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ - Yahoo Finance
Vaccine Makers Plunge After FDA Biologics Head Marks Steps Down - Bloomberg.com
Biopharma, Biotech stocks tumble on FDA shakeup - Investing.com India
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com Australia
Where are the Opportunities in (NVAX) - Stock Traders Daily
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
The industry heavyweight behind Novavax’s push to bounce back - PharmaVoice
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
Ebola Vaccine Market Generated Opportunities, Future Scope - openPR
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
(NVAX) Technical Pivots with Risk Controls - Stock Traders Daily
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying - The Motley Fool
Canada cancels Novavax Covid vaccine purchase - New Vision
Canada cancels purchase of Covid-19 vaccine from Novavax - БГНЕС
Some Novavax, Inc. (NASDAQ:NVAX) Analysts Just Made A Major Cut To Next Year's Estimates - Simply Wall St
Head to Head Analysis: TScan Therapeutics (NASDAQ:TCRX) versus Novavax (NASDAQ:NVAX) - Defense World
Novavax Announces Board Changes and Strategic Shift - TipRanks
Novavax appoints new chair as James Young retires By Investing.com - Investing.com Australia
Need To Know: Analysts Just Made A Substantial Cut To Their Novavax, Inc. (NASDAQ:NVAX) Estimates - Yahoo Finance
Federal government cancels deal with US company to make COVID-19 vaccine in Montreal - Montreal Gazette
Novavax faces contract termination with Canadian government By Investing.com - Investing.com South Africa
Novavax falls as Canada terminates COVID-19 vaccine purchase deal - TradingView
Canada Cancels Novavax Covid Vaccine Purchase - Barron's
Novavax Faces Contract Termination with Canadian Government - TipRanks
Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows - Marketscreener.com
Novavax: retirement of the Chairman of the Board of Directors -March 11, 2025 at 09:55 am EDT - Marketscreener.com
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership - MSN
Novavax faces contract termination with Canadian government - Investing.com India
Novavax Chair James Young Retires; Margaret McGlynn Named Successor -March 11, 2025 at 09:02 am EDT - Marketscreener.com
Novavax appoints new chair as James Young retires - Investing.com India
Novavax Reshapes Leadership: Vaccine Industry Veteran Takes Board Chair Amid Strategic Shift - StockTitan
Novavax Applies Lessons Learned From Turbulent COVID-19 Experience - BioSpace
Novavax Inc Azioni (NVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.05%
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):